From 1/1-4/15, $9M cash raised via warrants. No offering until January 2020!


****BIG INSIDER BUYS AT MARKET PRICE****

On 5/7,  Geert "purchased another $100,000 worth of restricted CEL-SCI stock at $6.86 directly from the Company at the full market price. Several others from our senior management team and one member of the Board of Directors have joined  Geert and purchased another $110,000 worth of CEL-SCI stock on the same terms. "

***INSTITUTIONAL INTEREST IS GROWING BY THE DAY***

Institutional Interest continues to grow and grow...


Complete Listing HERE


Some Highlights from last Q:


  • Vangaurd ADDED 58K and now has 985K
  • MMCAP was unchanged and has nearly 1.6M shares
  • Susquehanna quadrupled by adding 96K and now has 129K
  • Bridgeway tripled their position by 122K and now has 142K
  • Renaissance Tech is a new holder and they added 178K
  • Credit Suisse is new too and they added over 54K
  • Commonwealth Equity added 83K.  They now have 103K
  • D.A. Davidson added 99K.  They now have 400K

 

  • The IDMC announcement was at the end of Q1. Thus, many Tutes started buying after 3/31/2019.  I strongly suspect that Q2 will be much bigger.
  • From poster HR from Yahoo!:  "Steady accumulation by institutions. That is powerful proof investors are on more solid footing. Remember, EVERY institutional investor does their due diligence. They don't "just" have to report to themselves or their spouses. They have others they report to. "   Their JOBS and livelihoods are on the line!
  • The recent Tutes and private investors are waiting for Data/298 and will not sell until then. Thus, this will effectively reduce our Float and Volume. Epic Short Squeeze is coming!


Full Details on the Tutes Page

******ALERT******

CASH CASH BABY!

2nd Quarter 10Q was released recently and we have over $13M cash to work with.


Almost $9M in cash was received via warrant conversions from 1/1/19-4/15/19.  These were issued before August '18.  No offering until Spring 2020!

PRESS RELEASE HERE


Visit  Cash Page for more details!

You Just Bought CVM. We Message Board Posters Welcome You!

image344

About Cel-Sci and their Phase III drug candidate Multikine

Lots of good details can be found on their website: Cel-Sci.com.  But the best recap is their Corporate Presentation.  Link below:

CORPORATE PRESENTATION


Zacks provided a nice recap recently as well.  Link below:

ZACKS

Trial "should have" ended in December 2018, why the "delay"?

Delays are never good, right? Here is the thing...  The trial ends when the 298th event (death) happens.  But people aren't dying as fast as statistics would suggest for survival of Head and Neck cancer patients.  Why?  We believe its Multikine


The IDMC recently, 3/29/19, reviewed the UNBLINDED data for efficacy, safety and FUTILITY.  Their recommendation: Continue the trail until the last event!  Details Here


Need more proof and you're a Stats Junkie?  Then head on over to the Google Sheets created by our "National Treasure" FOSCO and team from the iHub message boards.  These sheets estimate that we are now past 10% of Standard Care.  These sheets take into account all different survival stats for Head and Neck cancer patients at 3 and 5 yrs.   Feel free to poke around...don't worry the sheets are protected and you cant mess anything up!


GOOGLE SHEETS

Straight from the CEO himself. BTW he has over 1M shares (bought more on 5/7)

On 5/16, a new interview is out:

Video


On 5/8, Geert issued a Press Release:

Shareholder Letter


Geert did an interview 5/2/19

ThinkEquity Interview 


4/11/19 Interview with Geert. Link below:

Interview


Geert recently gave some awkward dude an interview.  Link below:

MIDAS INTERVIEW

Musings by MellowMood from StockTwits (courtesy of MellowMood)

  • Ergomed  (CRO)  announced in  their  Annual  Report  that  they  expect to  finish  the  trial  1H19.  
  • Ergomed has a lot of "skin in the game"   Link  (They have direct access to trial data)
  • CVM had to extend ERGOMED ("CRO") contract because they thought trial would be over by now. Multikine ("MK") we believe is helping patients live longer. 
  • During phase 2 of the trial there was a 10% complete response to tumors. Completely eradicated.
  • IDMC just gave the go ahead to continue trial. Did not stop it for futility. The longer the trial goes the better the efficacy numbers. 
  • Recently just passed $5.00. Institutions will start to pour in. Heavily undervalued for a possible blockbuster in only head and neck cancer indication. 
  • Can use MK for many other cancers. So after FDA approval the long term potential for this stock can be $10B-$50B dollars. It’s not even $200M yet.
  • why it’s been steadily rising the last week. It’s fair value right now is $500M MINIMUM in my opinion as other companies are worth as much with only phase 2 trials.
  • Can be bought out for over a billion dollars at any moment. Happens all the time with potential blockbuster drugs. 
  • In 2016 the FDA removed their hold on the Phase 3 trial of MK. **According to their own guidelines, the FDA needs to see a "likelihood" of approval to remove the hold.**

$5 IS a Magic Number...Buckle Up!

We recently climbed over the "magic number" of $5.00.  What does that mean?


Many firms and funds use the below $5.00 mark as a designation as a "penny stock".  Most larger firms and funds will NOT let their Brokers solicit/buy a stock under $5.00.   In fact, it is in many of their Bylaws not to purchase stock under $5.00.


Here is a link to some additional information:

$5.00 IS MAGIC


But guess what, we are over the $5.00 mark and when I say "Giddy Up", I mean "Giddy Up!"


THIS WEBSITE SHOULD NOT BE CONSIDERED INVESTMENT ADVICE. THIS SITE WAS CREATED BY A NUT JOB WITH TOO MUCH TIME ON HIS HANDS.  THIS NUT JOB HAS SHARES OF CVM AND IS LONG.  THIS NUT JOB ISN'T BEING COMPENSATED FOR THIS SITE. ALL THESE OPINIONS ARE OF A NUT JOB.  

THE IDMC NEWS WAS HUGE

On 3/29/19, Cel-Sci released a PR stating that the IDMC has done their recent interim review and they made the following recommendation:


"continue the trial until the appropriate number of events have occurred."


PRESS RELEASE HERE


This is a big fucking deal!  At this point in the 8 year study, they have about 95% of all the data.  They would know if the study was futile or not.  If it was futile, they would have shut it down.


In the last 2 weeks the IDMC has shut down 3 trials for FUTILITY.  CVM just had the IDMC review their Phase III study for futility and recommended the trial should continue.  The 3 PRs link below are from the 3 recent trials that were just shut down:


 PRESS RELEASE HERE 

 

PRESS RELEASE HERE


PRESS RELEASE HERE


More about IDMC

NEW SEEKINGALPHA ARTICLE 4/10/19


 "This news set off a rally with the stock appreciating up to $6.27 on 4/9/19. They say no news is good news. Perhaps!. Some investors interpreted the continuation of the trial as potential good news that the HNSCC patients were responding to the immunotherapy and living longer. I understand the speculation because IDMC could have told Cel-Sci to stop the study for lack of futility. Cancer studies are very unpredictable, and I have explained in all my articles on my bullish thesis for the multikine immunotherapy. Cel-Sci is a high risk great reward play. "


SeekingAlpha

SHORTS ARE SPREADING RUMORS!

image345

Reverse Splits? Huh? That's Rich!!!!

 REVERSE SPLITS is the latest SHORT tactic!  Yes, we have had 3 Reverse Splits. But that was then due to low share price.  Did you know a Reverse Split REQUIRES Shareholder approval? Its true. This approval request is done via a Proxy. Here is the latest Proxy from a few weeks back: 

PROXY


****DID YOU SEE ANY REQUEST FOR AN APPROVAL OF A REVERSE SPLIT!?***


Furthermore, why would we do a Reverse Split now that we are at $5.00?  Are we at threat to be delisted?  No!  Here is why companies do Reverse Splits: 

REVERSE SPLIT INFO

Cash Cash and More Cash!

 This is always an issue with Biotechs.  Constant financing.  Dilution.  Wash, Rinse, Repeat.


The last 10Q as of 3/31/19 stated they have over $13M of cash.  No offering until early 2020!


Visit  Cash Page  for  current  details

The Stock Price Will Never Amount To Anything! Really?

Really?  We currently have a $180M (as of 4/8/19) Market Cap and a share price over $5.00.  Do some due diligence.  Upon a successful read out of the Phase III data, we are talking Billions and Billions!  I wont give you share price expectations, but what I will give you is recent buyouts of other bios:



Do the math!  We are at $150M with about 33M shares outstanding....How does one get to a $5B-$10B. Market Cap...?  The multiples are insane, but its possible!

Shorts Will Lie, Lie and Lie

Bashers Bash.  See why here: https://messageboardfools.com/bashers.htm 


They will say anything to make your give up your shares.  Stay long!

THIS WEBSITE SHOULD NOT BE CONSIDERED INVESTMENT ADVICE. THIS SITE WAS CREATED BY A NUT JOB WITH TOO MUCH TIME ON HIS HANDS.  THIS NUT JOB HAS SHARES OF CVM AND IS LONG.  THIS NUT JOB ISN'T BEING COMPENSATED FOR THIS SITE. ALL THESE OPINIONS ARE OF A NUT JOB.